Summary
Oncology clinical trials are central to advancing cancer treatment, yet many face delays and risks of failure due to underperforming trial sites. Rescue and optimization strategies for these sites are essential to preserving study integrity, safeguarding patient outcomes, and accelerating therapeutic innovation. This paper examines approaches to revitalizing underperforming clinical trial sites in high-stakes oncology studies, where timeliness and data quality are critical. Common challenges at such sites include inadequate patient recruitment, protocol deviations, high data query rates, and insufficient adherence to Good Clinical Practice (GCP) standards. These issues not only compromise study timelines but also threaten the validity of trial outcomes. Effective rescue interventions requi
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.